Natera announces ruling in favor of the company in CareDx false advertising case

Natera (NTRA) announced that the United States District Court for the District of Delaware issued a decision in favor of Natera in the false advertising case brought by CareDx (CDNA). In this decision, the court reversed findings returned by a jury in March 2022 and ruled that CareDx is not entitled to any damages. The decision also noted that CareDx showed no evidence that any person was deceived by or relied on any of the advertisements at issue in the case. Separately, the jury’s March 2022 verdict that CareDx engaged in false advertising against Natera, in violation of the Lanham Act, remains in place.